Rankings
▼
Calendar
GUTS Q4 2022 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
GUTS
Fractyl Health, Inc. Common Stock
$35M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$11M
EPS (Diluted)
$-0.23
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$907,000
Balance Sheet
Total Assets
$61M
Total Liabilities
$313M
Stockholders' Equity
-$252M
Cash & Equivalents
$49M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$11M
-$12M
+4.7%
Net Income
-$11M
-$13M
+13.3%
← FY 2022
All Quarters
Q1 2023 →